Transpharmation Limited was established as a limited company on August 17th, 2010 and operates from The London Bioscience Innovation Centre in London, NW1 0NH. Currently operating under Reg: 07348226, the firm is classified as an active entity within the professional scientific and technical activities n.e.c sector. Transpharmation specializes in providing comprehensive preclinical neuroscience research services to clients globally. The core focus of their offerings lies in facilitating the development of novel therapeutics for neurological disorders through rigorous biological studies. They offer a broad range of custom synthesis, animal model development, pharmacology testing, and data analysis support tailored to complex neuroscience challenges. As an international CRO, Transpharmation maintains a significant presence with established relationships across Europe, North America, and Asia. Their workforce is comprised primarily of skilled scientists and technicians dedicated to delivering high-quality research solutions. While not currently actively hiring, the company's strategic focus remains firmly on preclinical neuroscience – a vital area for drug discovery and development. The firm’s SIC codes encompass various professional scientific and technical activities, including but not limited to: Clinical Research Organization, Contract Research Services, Laboratory Development, Animal Model Design, and Custom Synthesis.

Transpharmation Limited was established as a limited company on August 17th, 2010 and operates from The London Bioscience Innovation Centre in London, NW1 0NH. Currently operating under Reg: 07348226, the firm is classified as an active entity within the professional scientific and technical activities n.e.c sector. Transpharmation specializes in providing comprehensive preclinical neuroscience research services to clients globally. The core focus of their offerings lies in facilitating the development of novel therapeutics for neurological disorders through rigorous biological studies. They offer a broad range of custom synthesis, animal model development, pharmacology testing, and data analysis support tailored to complex neuroscience challenges. As an international CRO, Transpharmation maintains a significant presence with established relationships across Europe, North America, and Asia. Their workforce is comprised primarily of skilled scientists and technicians dedicated to delivering high-quality research solutions. While not currently actively hiring, the company's strategic focus remains firmly on preclinical neuroscience – a vital area for drug discovery and development. The firm’s SIC codes encompass various professional scientific and technical activities, including but not limited to: Clinical Research Organization, Contract Research Services, Laboratory Development, Animal Model Design, and Custom Synthesis.